Chronic Pain Management, Mobile Technology and Clean Energy in This Week's Small-Cap Specialists Research Reports
NEW YORK, NY--(Marketwired - May 3, 2013) - Competitive Technologies, ( OTCQX : CTTC ), distributor of a non-narcotic and non-invasive medical device for the treatment of chronic pain, may be entering a "Perfect Storm" of media exposure and corporate developments in the next few weeks. The American Society of Clinical Oncology (ASCO) has an upcoming Annual meeting where promising technologies and biopharmaceutical advances are presented to the cancer medical community. These presentations can have a dramatic effect on the share prices of publicly-held companies to the degree that the SEC has asked ASCO to enforce a news embargo until May 15, when all presentations on the schedule for the ASCO meeting are posted on the ASCO website. CTTC's Calmare medical device has been in clinical studies with the Mayo Clinic, University of Wisconsin and Virginia Commonwealth University. And all three institutions are expected to release their patient data very soon. There is no guarantee that Calmare will be the subject of a presentation at the ASCO meeting, but there is speculation that at least one of the three institutions will be highlighting Calmare and its effects on chronic pain patients suffering from neuropathic pain. With only 16.4 Million shares outstanding, a recent price of $0.235 and considering the details -- including TV news videos -- in the CTTC Research Report available here, CTTC is one to watch for potential gains in May (CTTC websites: http://www.competitivetech.net/ and www.calmarett.com ). Much more on CTTC in the CTTC Research Report available here: http://bit.ly/OTCBBRESEARCH
GDT T e k, Inc . ( PINKSHEETS : GDTK ) is a Florida-based publicly traded company ( PINKSHEETS : GDTK ) focused on renewable and sustainable energy technologies. The company has licensed patented waste heat to electric power generation technology and is driving its adoption by power plants, landfills and other waste-heat generating industries. GDT Tek's waste heat to electricity systems are powerful enough to serve as a primary energy source, highly efficient, immediately cash-flow positive when installed under a Power Purchase Agreement and are scalable with system sizes from 150 KW/Hr. to 5000 KW/Hr. currently available. The GDT Tek system has been proven through a long-term five year installation at a San Jose, California-area landfill. Waste heat captured from landfill-generated methane gas generator engine exhaust and radiator jacket coolant systems is used by the GDT Tek system to generate electricity which is then sold to the grid. GDT Tek's heat to power conversion technology solution is proven to be the most reliable, versatile, efficient, lowest emissions, and overall cost-effective solution available in today's changing world market . Recent company updates and more can be found in our full research report here: http://bit.ly/OTCBBRESEARCH
Medizone International Inc. ( OTCQB : MZEI ) has enjoyed a recent upswing in the PPS and increased trading. MZEI announced on April 11 th , 2013 that an agreement has been reached with Canada's largest distributor of sanitary products. Management has recently shared their assessment of the current interest in their stock. To view the full assessment and research report click here: http://bit.ly/OTCBBRESEARCH
Hii Technologies, Inc. ( OTCQB : HIIT ) has investors very excited over recent revenue announcements and future potential earnings. Since the press release issued on April 10 th , 2013 stating that the revenues were up over 300% for the quarter ending March 31 st , 2013 from the same quarter in 2012, the PPS has risen nearly 39%. To learn more about future potential earnings and Q and A session with the Mathew Flemming, CEO of HIIT , follow the link provided: http://bit.ly/OTCBBRESEARCH
Receive mobile alerts and a free VIP member ship : text "OtcbbAlerts" to 25827
Disclaimer : Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have NOT been compensated for the mention of any of the companies in this press release.
Contact:
Susan Laidler
Senior Editor Email Contact
